Debra Cahn, Rac, Rqap Gcp
About Debra Cahn, Rac, Rqap Gcp
Debra Cahn is a Senior Manager of Clinical Quality Assurance at CytomX Therapeutics, specializing in health authority inspections and quality management systems. She has extensive experience in clinical compliance, having previously worked at Array BioPharma and Gilead Sciences.
Work at CytomX Therapeutics
Debra Cahn serves as the Senior Manager of Clinical Quality Assurance at CytomX Therapeutics, a role she has held since 2019. In this position, she focuses on health authority inspections and the development of quality management systems. Cahn ensures compliance with regulatory requirements while supporting program goals and timelines. Her responsibilities include facilitating investigations of quality events and liaising with supplier quality functions to track Corrective and Preventive Action (CAPA) status.
Previous Experience at Array BioPharma Inc
Prior to her current role, Debra Cahn worked at Array BioPharma Inc as a Clinical QA Specialist from 2009 to 2013. During her four years in Boulder, Colorado, she contributed to quality assurance processes within clinical trials, enhancing compliance and operational efficiency.
Experience at Gilead Sciences
From 2014 to 2019, Debra Cahn held the position of Associate Manager of Clinical Compliance at Gilead Sciences in Foster City, California. In this role, she was responsible for overseeing compliance-related activities and ensuring adherence to regulatory standards within clinical operations.
Education and Expertise
Debra Cahn earned a Bachelor of Science (BS) degree from Butler University. Her educational background supports her expertise in clinical quality assurance and compliance. She specializes in developing clinical compliance programs that encompass risk assessment, audit planning, and Good Clinical Practice (GCP) training.
Achievements in Clinical Compliance
Cahn has developed an overarching clinical compliance program that integrates various components, including risk assessment, audit planning, and GCP training. Her work includes the selection and oversight of consultants, contributing to the overall quality management within clinical trials.